Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00747 | DGN549 | |
| DGN549 is an innovative ADC cytotoxin with optimized linker technology, providing efficient payload release and enhanced tumor targeting in antibody-drug conjugates for precision oncology. Keywords: ADC linker, cytotoxin payload, targeted drug conjugate, tumor specificity. | Inquiry | |
| BADC-00748 | MPB-vc-PAB-MMAE | |
| MPB-vc-PAB-MMAE is a drug-linker conjugate for ADC by using monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via MPB-vc-PAB. | Inquiry | |
| BADC-00749 | MPB-MMAF | |
| MPB-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via MPB. | Inquiry | |
| BADC-00751 | DBCO-PEG4-MMAF | 2360411-65-8 |
| DBCO-PEG4-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via DBCO-PEG4. | Inquiry | |
| BADC-00752 | DBCO-PEG4-Ahx-DM1 | |
| DBCO-PEG4-Ahx-DM1 is a drug-linker conjugate for ADC by using DM1 (Maytansinoid DM1, a microtubulin inhibitor), linked via DBCO-PEG4-Ahx. | Inquiry | |
| BADC-00753 | DBCO-PEG4-vc-PAB-Duocarmycin SA | |
| DBCO-PEG4-vc-PAB-Duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB. | Inquiry | |
| BADC-00754 | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA | |
| DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB-(PEG2). | Inquiry | |
| BADC-00755 | DBCO-PEG4-VA-PBD | |
| DBCO-PEG4-VA-PBD is a drug-linker conjugate for ADC by using PBD (Pyrrolobenzodiazepine dimers, a potent antitumor antibiotic), linked via DBCO-PEG4-VA. | Inquiry | |
| BADC-00757 | DBCO-PEG4-vc-PAB-MMAD | |
| DBCO-PEG4-vc-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via DBCO-PEG4-vc-PAB. | Inquiry | |
| BADC-00758 | DBCO-PEG4-vc-PAB-Duocarmycin TM | |
| DBCO-PEG4-vc-PAB-Duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB. | Inquiry | |
| BADC-00759 | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin TM | |
| DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB-(PEG2). | Inquiry | |
| BADC-00760 | DBCO-PEG4-vc-PAB-Duocarmycin DM | |
| DBCO-PEG4-vc-PAB-Duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB. | Inquiry | |
| BADC-00761 | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin DM | |
| DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB-(PEG2). | Inquiry | |
| BADC-00762 | DBCO-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-56-2 |
| DBCO-PEG4-VC-PAB-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via DBCO-PEG4-VC-PAB-DMEA. | Inquiry | |
| BADC-00763 | DBCO-PEG4-DMEA-PNU159682 | |
| DBCO-PEG4-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via DBCO-PEG4-DMEA. | Inquiry | |
| BADC-00764 | DBCO-PEG4-GGFG-DX8951 | |
| DBCO-PEG4-GGFG-DX8951 is a drug-linker conjugate for ADC by using DX8951 (Synonyms: Exatecan, a DNA topoisomerase I inhibitor), linked via DBCO-PEG4-GGFG. | Inquiry | |
| BADC-00765 | DBCO-PEG4-vc-PAB-Ahx-DM1 | |
| DBCO-PEG4-vc-PAB-Ahx-DM1 is a drug-linker conjugate for ADC by using DM1 (Maytansinoid DM1, a microtubulin inhibitor), linked via DBCO-PEG4-vc-PAB-Ahx. | Inquiry | |
| BADC-00766 | DBCO-PEG8-VA-PAB-SG3199 | |
| DBCO-PEG8-VA-PAB-SG3199 is a drug-linker conjugate for ADC by using SG3199 (a PBD dimer,has a potently cytotoxic against cancer cell lines), linked via DBCO-PEG8-VA-PAB. | Inquiry | |
| BADC-00768 | Gly3-MMAF | |
| Gly3-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via Gly3. | Inquiry | |
| BADC-00769 | Gly5-Ahx-DM1 | |
| Gly5-Ahx-DM1 is a drug-linker conjugate for ADC by using DM1 (Maytansinoid DM1, a microtubulin inhibitor), linked via Gly5-Ahx. | Inquiry |
